Wolverine Asset Management’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,500
| Closed | -$94K | – | 2240 |
|
|
2022
Q3 | $94K | Sell |
9,500
-6,261
| -40% | -$62K | ﹤0.01% | 1148 |
|
|
2022
Q2 | $154K | Buy |
15,761
+1,800
| +13% | +$17.6K | ﹤0.01% | 1024 |
|
|
2022
Q1 | $137K | Buy |
13,961
+9,220
| +194% | +$90.5K | ﹤0.01% | 1024 |
|
|
2021
Q4 | $47K | Sell |
4,741
-4,412
| -48% | -$43.7K | ﹤0.01% | 1227 |
|
|
2021
Q3 | $91K | Buy |
9,153
+1,041
| +13% | +$10.4K | ﹤0.01% | 1036 |
|
|
2021
Q2 | $81K | Sell |
8,112
-1,888
| -19% | -$18.9K | ﹤0.01% | 1313 |
|
|
2021
Q1 | $98K | Buy |
+10,000
| New | +$98K | ﹤0.01% | 1222 |
|